Compound information
- Natural Products
- ZC3407026
- Molecular Formula
- C32H33ClN8O2
- Molecular Weight
- 596.241499976 g/mol
- Structure
-
- IUPAC Name
- N-(2-chloro-6-methyl-phenyl)-2-[4-(4-methylpiperazin-1-yl)anilino]-6-[2-(prop-2-enoylamino)phenyl]imino-1H-pyrimidine-5-carboxamide
- InChI
- InChI=1S/C32H33ClN8O2/c1-4-28(42)36-26-10-5-6-11-27(26)37-30-24(31(43)38-29-21(2)8-7-9-25(29)33)20-34-32(39-30)35-22-12-14-23(15-13-22)41-18-16-40(3)17-19-41/h4-15,20H,1,16-19H2,2-3H3,(H,36,42)(H,38,43)(H2,34,35,37,39)
- InChI Key
- HLRQYOGLZWIOPA-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccccc1N=c1[nH]c(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl
- Source
- ZINC001857576738
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 43 | Ring Count | 5 |
Heteroatom Count | 11 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 117.75 Å2 | LogP | 4.241 |
LogS | -5.73 | LogD | 3.565 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.141 | Pgp substrate | 0.236 |
HIA | 0.951 | F20 % | 0.933 |
F30 % | 0.622 | Caco-2 | -5.123 |
MDCK | -5.218 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.02 | PPB | 96.913 |
VD | 1.422 | Fu | 1.933 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.04 | CYP1A2 substrate | 0.705 |
CYP2A6 substrate | 0.316 | CYP2B6 substrate | 0.567 |
CYP2C19 inhibitor | 0.449 | CYP2C19 substrate | 0.853 |
CYP2C8 substrate | 0.955 | CYP2C9 inhibitor | 0.177 |
CYP2C9 substrate | 0.834 | CYP2D6 inhibitor | 0.257 |
CYP2D6 substrate | 0.945 | CYP2E1 substrate | 0.4 |
CYP3A4 inhibitor | 0.374 | CYP3A4 substrate | 0.988 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.339 | CL | 2.574 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.695 | Hepatotoxicity | 0.996 |
Mutagenicity | 0.009 | Rat Oral Acute Toxicity | 0.407 |
FDAMDD | 0.575 | Skin Sensitization | 0.81 |
Carcinogenicity | 0.072 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.804 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.543 | IGC50 | 4.735 |
LC50FM | -5.758 | LC50DM | -4.273 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.391 | NR-AR-LBD | 0.642 |
NR-AhR | 0.971 | NR-Aromatase | 0.32 |
NR-ER | 0.68 | NR-ER-LBD | 0.634 |
NR-PPAR-gamma | 0.926 | SR-ARE | 0.953 |
SR-ATAD5 | 0.934 | SR-HSE | 0.67 |
SR-MMP | 0.967 | SR-p53 | 0.947 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.